Know Labs, Inc. (KNW)
NYSEAMERICAN: KNW · Real-Time Price · USD
0.249
+0.009 (3.92%)
At close: Nov 22, 2024, 3:25 PM
0.247
-0.002 (-0.96%)
After-hours: Nov 22, 2024, 7:52 PM EST
Company Description
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.
The company’s proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.
The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018.
Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.
Know Labs, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 11 |
| CEO | Ronald Erickson |
Contact Details
Address: 500 Union Street, Suite 810 Seattle, Washington 98101 United States | |
| Phone | 206 903 1351 |
| Website | knowlabs.co |
Stock Details
| Ticker Symbol | KNW |
| Exchange | NYSEAMERICAN |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001074828 |
| ISIN Number | US4992381032 |
| Employer ID | 90-0273142 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Ronald P. Erickson J.D. | Founder, Chief Executive Officer, Treasurer and Chairman |
| Peter Joseph Conley | Chief Financial Officer and Senior Vice President of Intellectual Property |
| Dr. John Cronin | Interim Chief Technology Officer and Independent Director |
| Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific and Regulatory Advisory Board |
| Leonardo Trautwein | Chief Commercial Officer |
| Jordyn Hujar | Chief of Staff |
| Dr. Dominic Klyve Ph.D. | Chief Science Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 10-K | Annual Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 28, 2024 | 8-K | Current Report |
| Oct 9, 2024 | 8-K/A | [Amend] Current report |
| Oct 7, 2024 | DEF 14A | Other definitive proxy statements |
| Oct 2, 2024 | 8-K | Current Report |
| Sep 27, 2024 | 8-K | Current Report |
| Sep 26, 2024 | PRE 14A | Other preliminary proxy statements |
| Sep 11, 2024 | 8-K | Current Report |
| Aug 16, 2024 | 8-K | Current Report |